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Abstract The cystic fibrosis transmembrane conductance
regulator (CFTR) is a Cl− channel that governs the quantity
and composition of epithelial secretions. CFTR function is
normally tightly controlled as dysregulation can lead to life-
threatening diseases such as secretory diarrhoea and cystic
fibrosis. CFTR activity is regulated by phosphorylation of its
cytosolic regulatory (R) domain, and ATP binding and hydro-
lysis at two nucleotide-binding domains (NBDs). Here, we
report that CFTR activity is also controlled by extracellular
Cl− concentration ([Cl−]o). Patch clamp current recordings
show that a rise in [Cl−]o stimulates CFTR channel activity,
an effect conferred by a single arginine residue, R899, in
extracellular loop 4 of the protein. Using NBD mutants and
ATP dose response studies in WT channels, we determined
that [Cl−]o sensing was linked to changes in ATP binding
energy at NBD1, which likely impacts NBD dimer stability.
Biochemical measurements showed that increasing [Cl−]o
decreased the intrinsic ATPase activity of CFTR mainly
through a reduction in maximal ATP turnover. Our studies
indicate that sensing [Cl−]o is a novel mechanism for regulat-
ing CFTR activity and suggest that the luminal ionic environ-
ment is an important physiological arbiter of CFTR function,
which has significant implications for salt and fluid homeo-
stasis in epithelial tissues.
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Introduction
The cystic fibrosis transmembrane conductance regulator
(CFTR) is an anion channel which plays a crucial role in
regulating salt and fluid transport in the airways, sweat glands
and the gastrointestinal and genital tracts [36, 26]. Loss of
function mutations in CFTR cause the fatal inherited disease
cystic fibrosis (CF) [32], while overactive CFTR in the GI
tract leads to secretory diarrhoea [41]. CFTR is composed of
two transmembrane domains (TMDs), each consisting of six
transmembrane spans connected by extracellular loops
(ECLs), plus two cytosolic nucleotide-binding domains
(NBDs) and a large regulatory (R) domain [36, 32]. There
are also a number of positively charged residues in the ECLs
and outer pore [32, 19]. The positions of these residues and the
other major domains of CFTR are shown in Fig. 1a. Opening
of CFTR requires cAMP/PKA-dependent phosphorylation of
the R domain followed by the binding of two ATP molecules;
one to site 1 of NBD1 and one to site 2 of NBD2, which
induces dimerisation of the NBDs in a head-to-tail fashion and
leads to opening of the ‘gate’ located in the TMDs (see [23]
for a recent review). Channel closing is caused by ATP hy-
drolysis at site 2 and the subsequent release of ADP and Pi
drives disassembly of the NBD dimer [16, 40]. Because site 1
lacks a number of essential (conserved) residues necessary for
efficient nucleotide hydrolysis, ATP remains bound at this site
much longer than at site 2. Therefore, it is believed that events
at site 2 mainly terminate channel openings [6, 2, 5]. However,
recent work indicates that ATP binding to site 1 also contrib-
utes to the stability of the open state [49], and therefore has an
important, but less well-defined, role in CFTR gating.
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Extracellular (i.e. luminal in the physiological situation)
Cl− concentration ([Cl−]o) can regulate the function of CFTR.
We have shown that an increase in [Cl−]o enhances CFTR
activity, both in cell-free, inside out, as well as whole cell
patch clamp recordings [29, 44], indicating that a change in
channel gating, not channel numbers, underlies the response.
Others have reported that a reduction in [Cl−]o alters the
HCO3
−/Cl− permeability ratio and the conductance of the
channel [35, 27]. Because most CFTR-expressing epithelia
secrete substantial amounts of Cl− and HCO3
− (up to 140 mM
HCO3
− in the case of the pancreas [3]), and because the
concentrations of these anions in the luminal fluid varies
under physiological conditions [39, 25, 33, 37, 43], such
studies have led to the speculation that CFTR may be regu-
lated by the Cl− content of its own secretions [44, 27]. How-
ever, how [Cl−]o is sensed by epithelial cells and how changes
in [Cl−]o are communicated to CFTR in order to modulate its
gating, permeability and conductance are fundamentally im-
portant questions that have not been answered.
The goal of this study was to establish if CFTR itself could
act as an extracellular Cl− sensor and control its own gating.
To address this question, wild type (WT) and mutant forms of
CFTRwere heterologously expressed in mammalian cells and
the response to changes in [Cl−]o studied using the patch
clamp technique. CFTR was also purified and the effect of
[Cl−] on its ATPase activity measured to determine if Cl−
sensing constitutes an intrinsic property of the CFTR protein.
Materials and methods
Cell culture, plasmids and transfection Plasmids were con-
structed using either the pIRES2-EGFP (CLONTECH Labo-
ratories, Inc., Mountain View, CA, USA) or pBudCE4.1
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Fig. 1 Molecular structure of
CFTR. a Cartoon of the CFTR
protein showing the location and
charge of the all amino acids
mutated in this study. Note that
the extracellular loops are not
drawn to scale. b Three-
dimensional homology model of
CFTR based on the work of
Dalton et al. [14], using PyMol
software indicating the relative
positions of R899, W401 and
E1371 residues to other regions of
note. Note that the homology
model lacks the R domain and
that in the right hand diagram, the
extracellular surface of CFTR is
orientated to face the reader.
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(Invitrogen, Burlington, ON, Canada) as described previously
[18, 7]. Human embryonic kidney (HEK 293) cells were
grown in high-glucose Dulbecco’s modified Eagle’s medium
(DMEM)with 10% fetal calf serum (FCS), and 1% penicillin
and streptomycin in a 5 % CO2 humidified atmosphere at
37 °C. HEK cells grown on glass coverslips were transiently
transfected with WT or mutant forms of human CFTR. Brief-
ly, plasmid DNA was pre-complexed with OptiMEM-with-
GlutaMAX (Invitrogen, Paisley, UK) and Lipofectamine
2000 (Invitrogen, Paisley, UK) for 15 min. Complexed
DNA was then diluted in supplement-free medium to
∼0.5 μg/ml and added to the cells. After 6 h at 37 °C and
5 % CO2, the medium was replaced with OptiMEM contain-
ing 5 % FCS. Transfected cells were identified by
epifluorescence and used 2 to 4 days after transfection. Ex-
pression levels of the DeltaR-CFTR constructs were augment-
ed by incubating cells at 27 °C in 5 mM sodium butyrate after
transfection [22]. For patch clamp experiments, cells were
studied at ∼40–50 % confluency on glass coverslips.
Electrophysiology Fast whole cell patch clamp recordings
(fWCR) and data analysis were performed as described pre-
viously [44]. Whole cell currents were recorded at room
temperature with an Axopatch 200B amplifier (Molecular
Devices Inc., Wokingham, UK) and steady-state current-volt-
age (I-V) relationships obtained by holding the membrane
potential (Vm) at 0 mV and clamping to ±100 mV in 20 mV
increments for 250 ms, with a 1-s interval between each pulse.
Current amplitudes were calculated at the reversal potential
(Erev) to ±60 mVand normalised to cell capacitance (pF). The
Erev was obtained by interpolation from I-V plots (x-axis
intercept obtained by fitting a fourth-order polynomial to the
I-V data points). After establishing a fWCR, the standard
experimental protocol was to measure: (1) control currents
in high (155.5 mM) Cl− bath solution, followed by forskolin
(10 μM)-stimulated currents (measured after at least 5-min
exposure to forskolin, FSK) in (2) high (155.5) mM Cl−, (3)
low (35.5 mM) Cl− and (4) high (155.5) mM Cl−. The per-
centage stimulation of CFTR activity by Cl−was calculated by
comparing the current amplitude at −60 mV from the Erev, in
low Cl−, with the average of the current amplitudes in high Cl−
immediately before and after exposure to low Cl−. We specif-
ically chose to report inward currents because this represents
the most relevant physiological situation (i.e. Cl− efflux).
Using this approach, the calculated percentage stimulation of
CFTR activity by external Cl− is independent of any change in
driving forces under the low and high Cl− conditions [44]. The
pipette (intracellular) solution contained (in mM) 139 CsCl, 2
MgCl2, 5 ethylene glycol-bis(B-aminoethylether)-N,N,N′,N′-
tetraacetic acid (EGTA), 10 HEPES, 5 glucose, 1 Na2ATP and
0.1 Na2GTP (pH=7.2) with CsOH. In the experiments using
different ATP concentrations or ATP analogues, the MgCl2
concentration was altered to maintain a 1 mM free Mg2+
concentration calculated on a 1:1 basis, with CsCl concentra-
tion adjusted to maintain Cl− concentration and osmolarity.
The high-chloride (155.5 mM) bath (extracellular) solution
contained (in mM) 145 NaCl, 4.5 KCl, 1 MgCl2, 2 CaCl2, 10
HEPES and 15 L-glutamic acid monosodium salt hydrate
(pH=7.4) with NaOH. For the 35.5-mM chloride solution,
120 mM NaCl was replaced with 120 Na aspartate. Forskolin
was purchased from Tocris Bioscience (Bristol, UK) and all
other chemicals from Sigma-Aldrich (Poole, UK).
Purification and reconstitution of CFTR The method for pu-
rification of CFTR from transfected Sf9 cells using perfluoro-
octanoate (PFO) has been described previously [15]. The
following modification was included. At the point of protein
elution from nitrilotriacetic acid beads during fast protein
liquid chromatography, the program was interrupted and the
protein was subjected to detergent exchange. The column was
first washed with 10 ml of a buffer containing 25 mM phos-
phate, 50 mM NaCl, 2 % PFO at pH 8.0. A second wash
consisted of 50 ml of buffer containing 25 mM HEPES,
100 mM NaCl, 1 mM n-dodecyl-β-D-maltopyranoside
(DDM) at pH 7.4. The final elution buffer (25 ml) contained
600 mM imidazole. The eluted protein was washed with
imidazole-free buffer and concentrated using an Amicon Ultra
centrifugal filter device (Milipore Corp. Billerica, MA, USA),
(100 kDa cutoff) to bring the imidazole concentration below
1 mM and the protein concentration not greater than
0.2 mg/ml. The protein was phosphorylated at 4 °C overnight
in the presence of 2 mM ATP, 5 mM Mg2+ and 200 nM of
protein kinase A catalytic subunit (PKA; Promega Corp.
Madison, WI, USA). CFTR was reconstituted into 5 mg of
phosphatidyl-ethanolamine (PE):phosphatidylserine
(PS):phosphatidylcholine (PC):ergosterol, 5:2:1:1 (w/v) or
5 mg Egg PC by incubation in the presence of DDM and lipid
for 30 min, followed by passage through an Extracti-Gel D
detergent-binding column (Pierce Corp. Rockford, IL, USA).
Purified CFTR was quantitated using an ELISA assay de-
scribed below and mixed at a ratio of ∼1:1,200 (protein:lipid,
w/w) with Egg PC and DDM.
ATPase assay of purified CFTR The ATPase activity of puri-
fied and PKA phosphorylated WT CFTR in DDM micelles
was measured as the production of inorganic phosphate in the
presence of Na-gluconate/NaCl (100 mM/50 mM NaCl) or
NaCl alone (150 mM) with approximately 2 μg CFTR protein
aliquot per reaction. Three independent purifications of WT
CFTR were studied. Phosphate release was determined using
the PiPer fluorescent assay (Invitrogen, Burlington, ON, Can-
ada), 1 h after initiation of the ATPase activity assay by the
addition of 0.05–1.0 mM ATP at 37 °C, in the presence of
either Na-gluconate/NaCl (100 mM/50 mM) or NaCl
(150 mM), using approximately 2 μg CFTR protein aliquot
per reaction. This assay enables the rapid evaluation of
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multiple experimental conditions simultaneously. A caveat of
studies of membrane proteins in detergent micelles is the
possibility that the detergent environment does not completely
recapitulate the interactions conferred by the lipid bilayer on
the membrane domains. However, DDM is commonly
employed in crystallography studies of the structure of mem-
brane proteins and, more specifically, we found that the
ATPase activity of DDM-solubilised CFTR was regulated
by PKA-dependent phosphorylation as expected from our
previous studies of lipid reconstituted CFTR [31].
Modelling of CFTR A three-dimensional homology model of
CFTR was created indicating the relative positions of R899,
W401 and E1371 residues (Fig. 1b), based on the work of
Dalton et al. [14], using PyMol software (The PyMOL Mo-
lecular Graphics System, Version 1.1 eval Schrödinger, LLC)
Statistics Data are presented as mean±SEM. Significance of
difference between mean values of different constructs was
tested either by one-way ANOVAwith Bonferroni’s Multiple
Comparison Test or Kruskal-Wallis followed with Dunn’s
Multiple Comparison test if Anderson-Darling normality test-
ing of the data showed the values were not normally
distributed.
Results
Role of ECL residues in the gating of CFTR by extracellular
Cl− concentration
To establish if CFTR was itself an extracellular Cl− sensor, the
positively charged residues in the ECLs of CFTR (R104,
K114, R117, K329, K892, R899, R1128) (Fig. 1a), as well
as R334 and K335 located at the putative outer mouth of the
channel pore [19] (Fig. 1a), were individually mutated to
neutral amino acids and the mutant channels tested for their
ability to respond to changes in [Cl−]o. Note that our previous
work found that gating of CFTR by [Cl−]o was voltage-
independent [44], and therefore unlikely to involve residues
further within the channel pore that experience the transmem-
brane electric field. Figure 2a illustrates the response of
cAMP-activated WT CFTR (cAMP levels increased by
FSK) to an increase in [Cl−]o from 35.5 to 155.5 mM, which
stimulated whole cell currents by 66.1±13.7 % (n=24), as we
have previously reported [44]. Figure 2b, c shows that remov-
ing the positive charge at position 899 (R899Q) completely
abolished [Cl−]o sensing by CFTR (high Cl
− stimulation; 4.3±
6.6 %, n=7), whereas all the other ECL charge neutralising
mutants had no significant effect on the response (Fig. 2c).
Furthermore, introducing a lysine residue in place of arginine
(R899K) maintained the response to [Cl−]o (Fig. 2c) while
mutating R899 to the negatively charged glutamic acid
(R899E) did not, clearly showing that the positive charge at
position 899 in ECL4 of CFTR is essential for [Cl−]o sensing.
Typical I-V plots obtained in this series of experiments for
WT, R899Q and the vector control are shown in Fig. 2b. The
effect of FSK on the CFTR currents and the Erev shifts on
switching to low [Cl−]o (an indication of the Cl
− selectivity of
the FSK-activated currents) for a number of different CFTR
constructs and experimental conditions are summarised in
Table 1.
Role of ATP hydrolysis and phosphorylation in [Cl−]o gating
of CFTR
We next investigated how changes in [Cl−]o were transduced
into a change in CFTR activity. Because gating of phosphor-
ylated CFTR is regulated by rounds of ATP binding and
hydrolysis at the two NBDs [36, 16, 23], we first focussed
on the role of ATP hydrolysis. Non-hydrolysable ATP ana-
logues are known to ‘lock’ PKA phosphorylated CFTR into
the open state upon binding to ATP binding site 2 on NBD2
(the site where rapid ATP hydrolysis normally occurs) [36,
16]. We first tested the effect of adding 1 mM adenosine
5′-(β,γ-imido)triphosphate lithium salt hydrate (AMP-PNP)
to the intracellular (pipette) solution, in the presence of 1 mM
ATP, with total MgCl2 increased to 3 mM, on WT channel
responses. Note that increasing the pipette MgCl2 to 3 mM on
its own had no significant effect on the degree of stimulation
by [Cl−]o (high Cl
− stimulation; 56.7±8.9 %, n=7). We con-
firmed that AMP-PNP was capable of locking open CFTR
under these conditions because the rate of current decay
following removal of FSK was markedly extended in the
presence of AMP-PNP (Fig. 3a). Figure 3b, c and f show that
AMP-PNP eliminated the [Cl−]o-dependent activation of
FSK-stimulated WT CFTR (high Cl− stimulation; −1.7±
3.7 %, n=5).
We then examined whether the ATP hydrolysis-deficient
CFTR mutant, E1371Q [38], could sense [Cl−]o with the
expectation that it would not. Like WT CFTR exposed to
AMP-PNP, the E1371Q mutant channels display extended
open channel bursts in the presence of ATP [16, 23, 40]. In
our experiments, E1371Q CFTR expressed in HEK cells was
constitutively active and large currents were detected without
prior stimulation with FSK (Fig. 3d (i) (first set of fWCR
current traces), and 3e), which agrees with previous work
performed in baby hamster kidney (BHK) cells [27, 42, 46].
The reason for this constitutive activity of E1371Q is unclear
and it contrasts with the behaviour of wild type CFTR and
other mutants (except DeltaR-CFTR) previously investigated
in our laboratories using the BHK and HEK cell expression
systems [46]. Exposing E1371Q CFTR (without FSK) to an
increase in [Cl−]o caused only a small stimulation of channel
activity (21.9±14.1 %, n=6; Fig. 3f). Surprisingly in view of
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the WT CFTR data with AMP-PNP, if E1371Q CFTR chan-
nels were first phosphorylated with FSK (which itself had no
significant effect on the size of the whole cell currents
(Fig. 3d (ii) (second set of fWCR traces)) and Table 1),
[Cl−]o sensing was restored (174.5±56.2 % stimulation,
n=8; Fig. 3d, e and f).
To confirm the role of phosphorylation in [Cl−]o sensing,
we reduced the endogenous phosphorylation of E1371Q
channels by removing ATP/GTP from the intracellular solu-
tion prior to stimulation with FSK, which significantly re-
duced basal E1371Q CFTR currents (No ATP/GTP: −186±
122 pA/pF n=8 vs ATP/GTP: −1,259±433 pA/pF, n=8,
P<0.001). Under these conditions, the E1371Q CFTR chan-
nels failed to respond to changes in [Cl−]o even in the presence
of FSK (Fig. 3f), consistent with the idea that only phosphor-
ylated channels are gated by [Cl−]o. Since E1371Q CFTR is
hydrolysis-deficient [38], we expected that [Cl−]o sensing by
the mutant would not be affected by AMP-PNP. However,
unexpectedly, we found that the ability of FSK-stimulated
E1371Q CFTR channels to respond to changes in [Cl−]o was
markedly reduced by the non-hydrolysable ATP analogue,
just like WT CFTR (Fig. 3f).
To check that the restoration of [Cl−]o sensing by E1371Q
CFTR after phosphorylation (Fig. 3d) was due to an
CA
B WT R899Q VEC 
WT 
(i)
(ii)
(iii)
(iv)
(i)
(ii)
(iii)
(iv)
R899Q 
Fig. 2 Arginine residue 889 in extracellular loop 4 of CFTR is essential
for [Cl−]o sensing. a Representative fWCR current recordings measured
between ±100 mV in 20 mV steps from HEK cells transfected with wild
type (WT) CFTR and R899Q CFTR, as indicated. The current traces are
from the top down: (i) unstimulated in 155.5 mM [Cl−]o, (ii) forskolin
(FSK)-stimulated in 155.5 mM [Cl−]o, (iii) FSK-stimulated in 35.5 mM
[Cl−]o and (iv) FSK-stimulated in 155.5 mM [Cl
−]o. Dotted line to the
right of the current traces indicates zero current level. b Representative I-
V plots for the Vector Control (VEC), WT and R899Q CFTR, for
unstimulated in 155.5 mM [Cl−]o (black squares); FSK-stimulated in
155.5 mM [Cl−]o (black rhombus); FSK-stimulated in 35.5 mM [Cl
−]o
(white circles) and FSK-stimulated in 155.5 mM [Cl−]o washoff (white
triangles). I-V plots were obtained from whole cell currents in a. All
constructs, except the vector control, showed positive Erev shifts (see
Table 1) on switching to low [Cl−]o consistent with the expression of a
Cl−-selective conductance. Note the different y-axis scales for the respec-
tive I-Vs. c Percentage stimulation of FSK-activated currents by [Cl−]o for
WT CFTR (n=24) and for different extracellular loop mutants (see
Fig. 1a) (n=4–9). Percent stimulation was calculated from I-V data at
−60 mV from the reversal potential, as described in “Materials and
methods.” Data are means±SEM. **p<0.01 compared to WT CFTR
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interaction of Cl− with the extracellular domain of CFTR, we
also studied the double-mutant R899Q-E1371Q. Figure 3f
shows that [Cl−]o sensing by the doublemutant in the presence
of FSKwas significantly reduced compared to E1371QCFTR
under the same conditions, confirming that phosphorylated
E1371Q CFTR channels respond to changes in [Cl−]o via
R899 in ECL4.
To explore the role of phosphorylation further, we studied
the effect of deleting the R domain from CFTR (residues 634–
836) [12, 7], which removes all the major PKA/PKC
Table 1 Summary of the FSK stimulation of whole cell currents and Erev shifts observed with the CFTR constructs used in this study
CFTR Construct n FSK Stimulation (%±SEM) Erev shift (mV±SEM)
WT (50 μM ATP) 5 180±96 15.0±3.6
WT (100 μM ATP) 6 12,000±6,000 15.2±3.0
WT (300 μM ATP) 8 1,200±600 17.0±3.0
WT (1 mM ATP) 24 13,000±6,000 23.7±1.8
WT (1.3 mM ATP) 9 1,400±900 16.7±2.6
WT (2 mM ATP) 24 6,100±5,300 16.7±1.6
WT (5 mM ATP) 7 1,600±1,000 20.1±4.4
WT (50 μM ATP + 50 μM P-ATP) 7 224±130 15.3±1.0
WT + Genistein 4 7,600±5,200 26.1±5.4
WT + AMP-PNP 5 2,800±2,500 21.8±5.5
WT (3 mM MgCl2) 7 28,000±17,000 18.3±3.1
R104Q 5 4,600±1,600 28.6±4.7
K114C 5 12,000±6,700 29.2±3.0
R117Q 4 33,000±20,000 30.1±3.4
K329A 5 13,000±10,000 33.7±2.1
R334Q 9 13,000±6,700 27.3±2.9
K335A 5 3,200±1,500 20.8±7.1
W401G 7 2,600±1,800 18.5±4.8
Delta-R (No Stim) 5 - 25.1±2.7
Delta-R (No FSK, Genistein) 5 140±13 22.7±3.0
Delta-R (FSK, No Genistein) 4 89±14 15.6±6.0
Delta-R (FSK + Genistein) 6 639±432 25.1±4.9
Delta-R-E1371S (No FSK) 9 - 21.4±4.8
Delta-R-E1371S (FSK) 4 2,600±1,400 15.3±4.7
K892Q 7 16,000±9,500 36.8±4.8
R899E 4 1,200±400 25.0±2.7
R899K 4 1,600±900 26.6±2.9
R899Q 7 5,400±2,800 30.0±1.3
R899Q + AMP-PNP 4 72,000±50,000 15.2±2.8
R899Q-E1371Q (No FSK) 4 - 18.4±5.9
R899Q-E1371Q (FSK) 6 107±48 15.6±3.0
R1128Q 6 14,000±6,100 41.1±4.2
Y1219G 6 3,200±2,500 19.2±3.3
E1371Q (No FSK) 6 - 25.5±3.5
E1371Q (FSK) 8 −28±9 22.3±4.0
E1371Q (FSK, No ATP, No GTP) 8 270±130 19.4±4.5
E1371Q + AMP-PNP (No FSK) 4 - 24.7±6.5
E1371Q + AMP-PNP (FSK) 8 180±170 17.4±4.0
Vector Control 4 15±38 -
FSK stimulation was calculated as the percentage increase in current density at −60mV from the Erev, after 5-min exposure to 10 μMFSK. TheErev shift
is the change inErev value on switching from 155.5 to 35.5mM [Cl
− ]o, in the presence of forskolin (see “Material andmethods”). TheErev shift predicted
by the Nernst equation for a perfectly selective Cl− conductance under these conditions is 37.5 mV. Note that because the vector control currents were
very small (Fig. 2b), the Erev shift is unreliable and not included in the Table
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consensus phosphorylation sites [36, 32]. Unlike WT CFTR,
DeltaR-CFTR channels are spontaneously active without PKA
phosphorylation, but are gated normally by cytosolic ATP [12,
7]. Note that because this mutant does not express very well in
HEK cells, we also included 30 μM genistein (a CFTR poten-
tiator, [1]) with FSK to increase the activity of DeltaR-CFTR
channels. Genistein itself had no effect on the ability of DeltaR-
CFTR (nor WT CFTR) to respond to changes in [Cl−]o (data
not shown), so the FSK and genistein results have been com-
bined. Figure 4a–e shows that both in the absence and presence
of stimulants (FSK + Genistein), DeltaR-CFTR exhibited WT-
like levels of [Cl−]o stimulation, indicating that deleting the R
domain removes the phosphorylation-dependence of [Cl−]o
sensing observed forWTCFTR (Fig. 2). Based on our previous
result that the phosphorylated, hydrolysis-deficient, E1371Q
mutant could sense [Cl−]o (Fig. 3f), we predicted that
preventing ATP hydrolysis at ATP binding site 2 of DeltaR-
CFTR would have no effect on [Cl−]o sensing. We tested this
prediction by using DeltaR-CFTR with the E1371S mutation,
which like E1371Q CFTR is hydrolysis defective [8] and
found, unexpectedly, that the double-mutant CFTR channels
did not respond to changes in [Cl−]o (external Cl
− stimulation;
no FSK/genistein: 0.0±7.0 %, n=9; with FSK/genistein: 16.7±
7.7 %, n=4) (Fig. 4c–e).
Role of ATP binding and ATPase activity of the NBDs
in [Cl−]o sensing by CFTR
Figures 3 and 4 suggest that the role of ATP hydrolysis in
[Cl−]o sensing by CFTR is complex; e.g. AMP-PNP abolishes
WT + AMP-PNP
4 
nA
100 ms
(i)
(ii)
(iii)
(iv)
E1371Q (FSK)
100 ms
30
 n
A
(i)
(ii)
(iii)
(iv)
E1371Q (FSK)
WT + AMP-PNPA
ED
CB
F
Fig. 3 Gating of CFTR by [Cl−]o requires ATP hydrolysis and phos-
phorylation. a AMP-PNP locks WT CFTR in the open state. Normalised
whole cell current density is plotted against time during FSK stimulation
(indicated by the dashed line) and the subsequent washoff in the absence
(squares, n=4) and presence (circles, n=4) of 1 mM AMP-PNP in the
pipette solution. b, d Representative fWCR current recordings measured
between ±100 mV in 20 mV steps from HEK cells transfected with WT
CFTR plus AMP-PNP and E1371Q CFTR, as indicated. The current
traces are from the top down: (i) unstimulated in 155.5 mM [Cl−]o, (ii)
forskolin (FSK)-stimulated in 155.5 mM [Cl−]o, (iii) FSK-stimulated in
35.5 mM [Cl−]o and (iv) FSK-stimulated in 155.5 mM [Cl
−]o.Dotted line
to the right of the current traces indicates zero current level. c, e Repre-
sentative I-V plots for the data presented in b and d. f Percentage
stimulation of either basal or FSK-activated currents by [Cl−]o for WT
CFTR (n=24), the ECL4 mutant R899Q, the hydrolysis-deficient mutant
E1371Q and the double-mutant R899Q-E1371Q (see Fig. 1) under
different conditions as indicated (n=4–8). Data are means±SEM.
*p<0.05, **p<0.01, ***p<0.001 between indicated datasets
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[Cl−]o sensing by WT CFTR, whereas the E1371Q mutation
has no effect. Possibly changes in ATP interaction with the
NBDs, and/or subsequent NBD dimerisation, rather than just
hydrolysis, could be primarily responsible for the effects of
[Cl−]o. To test this idea, we individually mutated key residues
involved in ATP binding at site 1 in NBD1 (W401) and site 2
in NBD2 (Y1219) to glycine (Fig. 1), and then measured
responses to changes in [Cl−]o. Note that both of these muta-
tions substantially reduce CFTR channel activity through
mechanisms that are not secondary to changes in ATP hydro-
lysis rate [49], and in the case of W401G, not due to an
apparent change in ATP binding affinity. Sub-panels a, b and
e of Fig. 5 show that the FSK-stimulated W401G CFTR
mutant exhibited significantly reduced [Cl−]o sensing com-
pared to WT CFTR, whereas the FSK-stimulated Y1219G
CFTR mutant did not (Fig. 5c–e).
We then reasoned that if events downstream of ATP bind-
ing to site 1, and/or NBD dimerisation, were altered by chang-
es in [Cl−]o (as the W401G data suggested), then the effect of
[Cl−]o on CFTR activity should be sensitive to the concentra-
tion of cytosolic ATP. Figure 5f shows that this was indeed the
case. [Cl−]o sensing by CFTR was gradually abolished as
cytosolic [ATP] was increased to ∼2 mM, with an estimated
IC50 of 1.15±0.14 mM, and a maximal stimulation of 80.0±
11.3 %. Consistent with the idea that ATP binding energy and/
or NBD dimerisation was being altered by [Cl−]o, we also
investigated the effect of including a higher affinity ATP
analogue, N6-(2-phenylethyl)-ATP (P-ATP, [48]), with a low
dose of ATP (50 μM). The presence of P-ATP (50 μM)
significantly reduced the ability of WT CFTR to respond to
changes in [Cl−]o when compared to the equivalent control
(100 μM ATP) response (Fig. 5f, open circle), further impli-
cating ATP/NBD interaction as a key factor in the activation of
CFTR by high [Cl−]o.
If high [Cl−]o activates CFTR by stabilising the NBD1-
NBD2 dimer, as suggested by the results in Fig. 5, we rea-
soned that the ATPase activity of WT CFTR (which is mostly
conferred by site 2; [38, 6]) should be reduced by high [Cl−].
To test this prediction, we performed ATPase measurements
on purified CFTR reconstituted into micelles and pre-
phosphorylated by PKA as previously described [15], over a
range of [ATP]. Figure 6 shows that when total [Cl−] was
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Fig. 4 Role of the R domain in [Cl−]o sensing by CFTR. a, c Represen-
tative fWCR current recordings measured between ±100 mV in 20 mV
steps from HEK cells transfected with deltaR-CFTR or deltaR-E1371S
CFTR as indicated. Note all experiments used unstimulated conditions.
The current traces are from the top down: (i) unstimulated in 155.5 mM
[Cl−]o, (ii) unstimulated in 35.5 mM [Cl
−]o and (iii) unstimulated in
155.5 mM [Cl−]o. Dotted line to the right of the current traces indicates
zero current level. b, dRepresentative I-V plots for the data presented in a
and c. e Percentage current stimulation by [Cl−]o for WT CFTR (n=24)
and for DeltaR and DeltaR-E1371Q mutants (see Fig. 1) under
unstimulated (No Stim) or after exposure to a combination of forskolin
and genistein (FSK/Genistein). (n=4–10). Data are means±SEM.
*p<0.05, **p<0.01 compared to indicated datasets
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increased from 50 to 150 mM (with total salt kept constant at
150 mM using Na-gluconate as a replacement for NaCl), there
was a marked shift in the ATPase activity curve, such that at
over the range of [ATP] up to 1.0 mM, there was a significant
decrease in ATPase activity. This change in ATPase activity
was due to a reduction in ATP turnover (Vmax for low [Cl
−];
114.3±1.5 nmol/h, n=3, versus high [Cl−]; 89.3±7.3 nmol/h,
n=4, p<0.04), without a significant change in apparent bind-
ing affinity (Km) of CFTR for ATP (Km for low [Cl
−]; 48±
12 μM, n=3 versus high [Cl−]; 69±16 μM, n=4, p>0.05).
Discussion
Our data provide the first evidence that [Cl−]o-dependent
stimulation of CFTR is an intrinsic property of the channel,
and that R899 located in ECL4 is absolutely essential for the
response. Although neutralization of the positive charge at
R899, as well as charge reversal, eliminated [Cl−]o sensing
by CFTR (Fig. 2), we have no direct evidence that Cl− ions
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Fig. 5 ATP binding to site 1, but not site 2, underlies [Cl−]o sensing by
CFTR. a, c Representative fWCR current recordings measured between
±100mVin 20mV steps fromHEK cells transfected withW401GCFTR
or Y1219GCFTR, as indicated. The current traces are from the top down:
(i) unstimulated in 155.5 mM [Cl−]o, (ii) forskolin (FSK)-stimulated in
155.5 mM [Cl−]o, (iii) FSK-stimulated in 35.5 mM [Cl
−]o and (iv) FSK-
stimulated in 155.5 mM [Cl−]o. Dotted line to the right of the current
traces indicates zero current level. b, d Representative I-V plots for the
data presented in a and c. e Percentage current stimulation by [Cl−]o for
WT CFTR (n=24) and for W401G (NBD1) and Y1219G (NBD2)
mutants (see Fig. 1) (n=7–8). Data are mean±SEM. **p<0.01 compared
toWTCFTR. f Percentage current stimulation by [Cl−]o forWT CFTR at
different cytosolic (pipette) ATP concentrations. Data are means±SEM
(n=5–24). Data points fitted using least squares fit of a log [inhibition] vs
response equation, with variable slope function and with no constraints or
weighting. The open circle shows the effect of including 50 μM P-ATP
with 50 μM ATP on the response to [Cl−]o. ***p<0.001 compared to
100 μM ATP
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Fig. 6 ATPase activity of CFTR is stimulated by a decrease in Cl−
concentration. Purified WT CFTR was reconstituted into
dodecylmaltoside (DDM) micelles in the presence of either 150 mM
(squares) or 50 mM Cl− (circles) and the ATPase activity measured over
a range of ATP concentrations, as described in the “Materials and
methods.” Data are means±SEM for 3 (low Cl−) or 4 (high Cl−) separate
purification/reconstitution experiments. Data points fitted using the
Michaelis Menten equation (r2=0.83 (NaCl) and r2=0.8 (NaGlu))
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actually bind to this residue. Nevertheless, we assume that
R899 must reside somewhere in the pathway between Cl−
binding and enhanced CFTR activity. In support of this con-
clusion, the stimulating effect of [Cl−]o cannot be due to the
ion entering the pore, since mutations that do affect CFTR Cl−
conductance (R104Q, R117Q, R334Q, K335A) have no ef-
fect on [Cl−]o stimulation (Fig. 2), and the one site that is
important for sensing (R899) does not affect Cl− conductance
[45, 47]. It is conceivable that the R899Q/E mutations cause
abnormal folding of CFTR, which results in a change in the
interaction between Cl− and some other residue in the protein.
However, we noticed no major differences in the expression
levels of WT CFTR and the R899 mutants, nor any effects of
R899 mutations on CFTR channel properties; e.g. cAMP
activation, which would be expected if there was a major
folding problem [45, 47].
We can make a number of conclusions about the molecular
mechanism involved in the [Cl−]o stimulation of CFTR. First,
cAMP/PKA-dependent phosphorylation is required for the
response inWTand E1371Q CFTR channels. However, since
[Cl−]o sensing still occurred when the R domain was deleted
(Fig. 4), the ability to respond to [Cl−]o must reside in other
domains. In intact CFTR, these are likely to be parts of the
protein that are regulated by the R domain once it is phos-
phorylated. Although the R domain is a relatively disordered
structure, there is evidence from NMR studies that regions of
the R domain interact with the NBDs [4, 9]. Upon phosphor-
ylation of the R domain, it is thought that these regions of
interaction change and that this allows the NBDs to dimerise
in the presence of ATP, thereby promoting channel opening
[36, 16, 23, 4, 9]. Therefore, in terms of facilitating [Cl−]o
sensing, both phosphorylation of the R domain and its dele-
tion are functionally equivalent (but see below).
Secondly, in phosphorylated CFTR channels, impairing
ATP hydrolysis using the E1371Q mutation did not prevent
[Cl−]o sensing. This result implies that chloride sensing does
not lead to a change in channel gating simply via a change in
ATPase activity. Although chloride sensing does cause a
modest change in intrinsic ATPase activity (Fig. 6), this can-
not account for the larger effects on channel gating. The fact
that [Cl−]o sensing is impaired in phosphorylated E1371Q
CFTR channels when AMP-PNP is present, is probably ex-
plained by AMP-PNP substituting for ATP in its actions. As
Fig. 5f shows, raising cytosolic [ATP] to 2 mM, or above,
abolished sensing. This is why AMP-PNP effects are mim-
icked by ATP, but not by the E1371Q mutation. In this
context, it is important to remember that although the
E1371Q mutation substantially reduces ATP hydrolysis
(∼70 %, [38]), the channel is still gated by ATP, even in a
DeltaR background [12, 7, 8]. The one caveat to this interpre-
tation is that [Cl−]o sensing by DeltaR-CFTR was abolished
when ATP hydrolysis at NBD2 was blocked by the E1371S
mutation. This result indicates that intra-domain interactions
in CFTR that lacks an R domain cannot fully recapitulate
those in WT CFTR, despite evidence that DeltaR-CFTR has
similar gating properties to WT CFTR [12, 7].
Thirdly, the fact that [Cl−]o sensing is abolished by the
W401G mutation in NBD1, but not by the corresponding
NBD2 mutant, Y1219G (Fig. 5e), suggests that ATP binding
at NBD1, and not NBD2, is mainly responsible for transduc-
ing the [Cl−]o-dependent gating changes. Furthermore, since
P-ATP also prevented [Cl−]o from changing CFTR activity
(Fig. 5f), then our results are best explained by external Cl−
affecting the stability of the NBD1/NBD2 dimer (more stable
at higher external Cl−). Thus both the presence of cytosolic P-
ATP as well high [Cl−]o converge on the same process.
Fourthly, changes in Cl− concentration, at constant Na+,
alters the intrinsic ATPase activity of intact CFTR by ∼20 %,
which argues for a direct effect of Cl− on the intrinsic catalytic
activity of the protein (Fig. 6). This result shows that in
addition to total salt concentration [24], Cl− concentration
alone can regulate the ATPase activity of purified CFTR and
appears to do this by altering the ATP turnover (hydrolysis)
rate by the NBDs. The mechanism for this change in ATP
turnover is uncertain at the present time. In addition, whether
substitution of arginine for glutamine at position 899 in ECL4
leads to a change in ATPase activity of the CFTR is an
important area for future research.
In conclusion, our results support a mechanism whereby an
increase in [Cl−]o stimulates CFTR activity by modulating
ATP binding/interaction at NBD1, which favours NBD
dimerisation, reducing ATP hydrolysis and hence increasing
channel activity. Thus our results suggest that the increased Po
of the CFTR channel that we reported previously under high
[Cl−]o conditions [44] is due to external Cl
− acting at ECL4 to
alter single channel gating. In addition, and in contrast to the
known effects on Po, an effect of external Cl
− on the number
of active channels (N) and the single channel current (i) can
effectively be ruled out. Thus the current paradigm that trans-
mission of ‘gating information’ in phosphorylated CFTR is
temporally and spatially directed from the cytosolic NBDs to
the TMDs needs to be revised. Specifically, our data shows
that an interaction of Cl−with externally accessible parts of the
TMDs also feeds back to modulate NBD function. How R899
in ECL4 alters CFTR gating is unclear; however, ECL4
connects transmembrane segments 7 and 8 in TMD2 and is
the largest ECL in CFTR and exhibits considerable flexibility
(Fig. 1b). Recent molecular modelling and cross-linking ex-
periments [21, 28, 34] predict that there are inter-domain
interactions between the TMDs and their opposite NBDs
through the intracellular loops (ICLs), which act as coupling
helices. Since TM segment 8 is connected to TM segment 9
via ICL3, and ICL3 has been shown to lie in close proximity
to NBD1, and to interact with the NBD-ATP binding sites
[28], then it is conceivable that Cl−-dependent alterations in
ECL4 are transmitted to NBD1 via ICL3.
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Altogether, our present results, together with previous stud-
ies [30, 20], demonstrate that the short ECLs of CFTR are
important for controlling channel activity. However, this study
is the first to provide an explanation for how an ECL residue
can alter CFTR gating via changes in the interaction of cyto-
solic ATP with CFTR NBDs. Interestingly, a recent study by
Cui et al. [13] has shown that three charged amino acid
residues in ECL1 (D110, E116 and R117) are involved in
stabilising the architecture of the outer pore of CFTR by
interacting with other charged residues, including K892 in
ECL4. Furthermore, our lab has recently demonstrated,
through cross-linking of residues in ECL1 and ECL4, that
the relative movement of these two ECLs is necessary for
normal channel gating [10] which further demonstrates the
important role of the ECLs in CFTR channel function.
We speculate that [Cl−]o sensing may be a feedback mech-
anism allowing CFTR to orchestrate anion and fluid secretion
in epithelial tissues that secrete an isotonic mixture of Cl− and
HCO3
− [25, 33, 37, 39, 43]. For instance, in pancreatic ducts,
luminal [Cl−] falls as luminal [HCO3
−] rises which would
limit CFTR activity and favour hyperpolarization of the lumi-
nal membrane, thus maintaining an electrical driving force for
HCO3
− secretion via either electrogenic SLC26 family anion
exchangers [26] or CFTR itself [3]. However, in tissues that
are thought to secrete little HCO3
−, such as the surface cells
lining the larger airways and nasal tract [17, 11], where ASL
[Cl−] is likely to remain high, then the mechanism we describe
is less likely to be of major significance. Finally, the [Cl−]o
sensing site in CFTR that includes R899 on its extracellular
face is a potential drug target for the correction of CF-causing
gating mutants if a compound could be developed that mim-
icked the stimulatory effect of [Cl−]o on the channel.
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